|
Volumn 352, Issue 5, 2005, Pages 509-511
|
Chemoradiotherapy for rectal cancer [1] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANUS SPHINCTER;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
HUMAN;
LETTER;
MULTIMODALITY CANCER THERAPY;
POSTOPERATIVE CARE;
PREOPERATIVE TREATMENT;
PRIORITY JOURNAL;
RECTUM ABDOMINOPERINEAL RESECTION;
RECTUM CANCER;
SURVIVAL TIME;
TUMOR VOLUME;
NOTE;
PATHOLOGY;
PREOPERATIVE CARE;
RECTUM;
RECTUM TUMOR;
ANAL CANAL;
RADIOTHERAPY;
METASTASIS;
TUMOR RECURRENCE;
RADIATION DOSE;
SURVIVAL;
ANTINEOPLASTIC AGENTS;
COMBINED MODALITY THERAPY;
HUMANS;
NEOPLASM STAGING;
POSTOPERATIVE CARE;
PREOPERATIVE CARE;
RECTAL NEOPLASMS;
RECTUM;
ANAL CANAL;
RADIOTHERAPY;
NEOPLASM METASTASIS;
NEOPLASM RECURRENCE, LOCAL;
RADIATION DOSAGE;
SURVIVAL ANALYSIS;
|
EID: 13744250231
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200502033520517 Document Type: Letter |
Times cited : (6)
|
References (0)
|